Search clinical trials for: Mesenchymal epithelial transition factor (MET)
Total 94519 results
-
European Society of AnaesthesiologyCompletedNon Cardiac SurgeryGermany
-
Poznan University of Physical EducationCompletedMuscle Energy Techniques and Trigger Point Therapy in Asymptomatic Persons With Latent Trigger PointAsymptomatic ConditionPoland
-
GlaxoSmithKlineCompleted
-
Boston Children's HospitalCompletedMarijuana AbuseUnited States
-
Riphah International UniversityCompleted
-
Novartis PharmaceuticalsWithdrawnCarcinoma | Non-Small-Cell Lung Cancer
-
Riphah International UniversityCompletedMechanical Low Back Pain | Muscle Stretching Exercises | Paraspinal MusclesPakistan
-
U&I CorporationCompleted
-
Sun Yat-sen UniversityGuangdong Provincial Hospital of Traditional Chinese Medicine; The Third Affiliated... and other collaboratorsRecruitingType 2 Diabetes MellitusChina
-
Foundation University IslamabadCompleted
-
Amsterdam UMC, location VUmcNational MS Foundation, The Netherlands; Voeding LeeftRecruiting
-
Samsung Medical CenterCompletedc-MET Positive Gastric CancerKorea, Republic of
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)CompletedHead and Neck CancerUnited States
-
Chang Gung UniversityCompletedMyogenous Temporomandibular Disorders (mTMD)Taiwan
-
NuBiyotaCompleted
-
Centre Oscar LambretCompletedNon Small Cell Lung CancerFrance
-
Elcelyx Therapeutics, Inc.CompletedType 2 Diabetes Mellitus
-
Novartis PharmaceuticalsCompletedCarcinoma, Non-Small-Cell LungItaly, Spain, Germany, Japan, Taiwan, Belgium, Netherlands, Singapore, Argentina, France, Israel, Sweden, Korea, Republic of, Lebanon, United Kingdom, United States, Austria, Mexico, Norway, Russian Federation
-
National Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast CarcinomaUnited States
-
October 6 UniversityCompletedDiabetic NeuropathiesEgypt
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingAdvanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification | Lung Adenocarcinoma Stage IIIB/IVSpain, Taiwan, United States, Korea, Republic of, Netherlands, Israel, Belgium, Italy, China, France, Germany, Japan, Poland, Austria, Switzerland
-
Otologics LLCUnknownMixed Conductive and Sensorineural Hearing Loss, Bilateral
-
National University Hospital, SingaporeUnknownSquamous Cell Carcinoma of the Head and Neck | Squamous Cell Carcinoma of the LungSingapore
-
Novartis PharmaceuticalsCompletedCarcinoma, Non-Small-Cell LungBelgium, Germany, Italy, France, Netherlands, Spain, Korea, Republic of, India, Brazil, Portugal
-
Obafemi Awolowo UniversityCompleted
-
Elcelyx Therapeutics, Inc.CompletedRenal Insufficiency
-
Novartis PharmaceuticalsTerminatedc-MET Inhibitor; PI3K Inhibitor, PTEN Mutations, Homozygous Del. of PTEN or PTEN Neg. by IHC, c-Met Ampli. by FISH, INC280, BKM120, Buparlisib; Recurrent GBMSpain, Switzerland, Germany, United States, Netherlands
-
Timothy Burns, MD, PHDNovartisRecruitingNon-small Cell Lung CancerUnited States
-
Guangdong Provincial People's HospitalShanghai Junshi Bioscience Co., Ltd.RecruitingNon-Small Cell Lung Cancer | BRAF V600 Mutation | MET Amplification | MET Exon 14 Skipping Mutation | RET Driver Mutation | Erb-B2 Receptor Tyrosine Kinase Exon 20 MutationChina
-
King Saud UniversityShah Physiotherapy Center, Delhi, IndiaCompletedMyofascial Trigger Point PainSaudi Arabia
-
UConn HealthNational Institute on Drug Abuse (NIDA)Completed
-
Cairo UniversityNot yet recruitingChronic Non Specific Low Back Pain
-
PfizerCompletedSystemic Anaplastic Large-Cell Lymphoma | Non-Small Cell Lung Cancer ALK-positive | Non-Small Cell Lung Cancer c-Met Dependent | Non-Small Cell Lung Cancer ROS Marker Positive | Advanced Malignancies Except LeukemiaUnited States, Korea, Republic of, Australia, Japan
-
St. Louis UniversityVA St. Louis Health Care SystemCompletedSubstance Use DisordersUnited States
-
University Health Network, TorontoPfizerRecruitingNon-squamous Non-small-cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | ROS1 Gene Rearrangement | MET Activating Mutation | MET AmplificationCanada
-
Mirati Therapeutics Inc.CompletedNon-Small Cell Lung CancerUnited States, Korea, Republic of, Hungary, United Kingdom, Italy, Australia, Taiwan, Poland, Canada
-
Corporacion Parc TauliCompleted
-
Dartmouth-Hitchcock Medical CenterNational Institute on Drug Abuse (NIDA)CompletedCannabis DependenceUnited States
-
University Hospital, Basel, SwitzerlandCompleted
-
Athira PharmaBiotrial Inc.; Alturas Analytics, Inc.Completed
-
Laboratorios Silanes S.A. de C.V.Suspended
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.RecruitingNon Small Cell Lung CancerChina
-
National Cancer Institute (NCI)TerminatedEpithelioid Mesothelioma | Sarcomatoid Mesothelioma | Stage IV Pleural Mesothelioma | Recurrent Malignant Mesothelioma | Stage II Pleural Mesothelioma | Stage III Pleural MesotheliomaUnited States
-
Dartmouth-Hitchcock Medical CenterNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Completed
-
UConn HealthDonaghue Medical Research FoundationCompleted
-
Daiichi Sankyo, Inc.ArQule, Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary...CompletedHepatocellular CarcinomaUnited States, France, Italy, Germany, Spain, Switzerland, Belgium, Portugal, Netherlands, Australia, Brazil, Canada, Austria, New Zealand, Sweden, Argentina
-
Riphah International UniversityCompleted
-
Haihe Biopharma Co., Ltd.UnknownNegative T790M Mutation and Met AmplificationChina
-
Avistone Biotechnology Co., Ltd.RecruitingNon-Small-Cell Lung CancerChina